Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.

Authors:
Le Houézec D.

Journal:
Immunol Res

Publication Year: 2014

DOI:
10.1007/s12026-014-8574-4

PMCID:
PMC4266455

PMID:
25395338

Journal Information

Full Title: Immunol Res

Abbreviation: Immunol Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The author declares that he has no conflict of interest."

Evidence found in paper:

"Most publications where there is no link between HB vaccination and the onset of MS [–] received grants from pharmaceutical industry. Other criticism that can be raised for some of these negative case–control studies is the limited period (2–24 months) of their survey [, –]. Moreover, the Hernan’s publication [] shows also a negative result (OR 1.8; CI 0.5–6.3) for a period of 1 year and becomes significant between 2 and 3 years of follow-up after HB immunization."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025